Brant Binder

Brant is a co-founder and currently President of ZebiAI Therapeutics, Inc. He also co-founded Psy Therapeutics and X-Body Biosciences, which was sold to JUNO Therapeutics in 2015. In addition, Brant is a past co-founder and BOD member of X-Chem Pharmaceuticals.

Prior to his involvement in the commercialization of DNA-encoded library platform companies, Brant was a founder and CEO of optical instrument company, SRU Biosystems. Brant began his career in venture capital and private equity investment at Trust Company of the West. He is a graduate of MIT’s Sloan School of Management (where he was a seed investor in Sohu.com) and of Georgetown University’s School of Foreign Service.